GENFLOW BIOSCIENCES PLC (WQ5) — Net Asset Quality Index
GENFLOW BIOSCIENCES PLC (WQ5) has a Net Asset Quality Index of -64.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €468.38K minus total liabilities of €771.38K yields net assets of €-303.00K. A higher index indicates a stronger, lower-leverage balance sheet. Read WQ5 total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
GENFLOW BIOSCIENCES PLC Net Asset Quality Index Over Time (2021–2024)
This chart shows how GENFLOW BIOSCIENCES PLC's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the index stands at -64.7%, representing net assets of €-303.00K against total assets of €468.38K EUR. For live market cap and overall valuation, see WQ5 company net worth.
Annual Net Asset Quality Index for GENFLOW BIOSCIENCES PLC (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for GENFLOW BIOSCIENCES PLC from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See GENFLOW BIOSCIENCES PLC shareholders equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -104.4% | €-403.01K | €385.91K | €788.92K | ▼ -151.1 pp |
| 2023 | 46.6% | €499.69K | €1.07 Million | €571.96K | ▼ -43.8 pp |
| 2022 | 90.4% | €2.37 Million | €2.62 Million | €250.99K | ▲ +70.5 pp |
| 2021 | 19.9% | €55.12K | €276.55K | €221.43K | — |